Amgen Inc.
AMGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.09 | -1.51 | 0.14 | -0.72 |
| FCF Yield | 2.80% | 1.27% | 0.58% | 3.12% |
| EV / EBITDA | 33.31 | 54.85 | 52.95 | 64.60 |
| Quality | ||||
| ROIC | 2.94% | 3.46% | 1.48% | 2.56% |
| Gross Margin | 67.75% | 67.15% | 63.58% | 65.75% |
| Cash Conversion Ratio | 1.46 | 1.59 | 0.80 | 7.61 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.25% | 9.50% | 9.22% | 8.29% |
| Free Cash Flow Growth | 122.29% | 95.00% | -77.73% | 32.77% |
| Safety | ||||
| Net Debt / EBITDA | 7.63 | 13.32 | 11.90 | 16.45 |
| Interest Coverage | 3.69 | 3.73 | 1.63 | 3.09 |
| Efficiency | ||||
| Inventory Turnover | 0.49 | 0.46 | 0.44 | 0.44 |
| Cash Conversion Cycle | 182.39 | 192.22 | 220.90 | 221.50 |